Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2012
05/10/2012US20120115943 Composition and method for neuroprotection against excitotoxic injury
05/10/2012US20120115942 Methods for Synthesizing Glycinols, Glyceollins I and II and Isoflavenes and Chromanes Using A Wittig Reaction, and Compositions Made Therewith
05/10/2012US20120115941 Compounds Affecting Glycemic Index
05/10/2012US20120115940 Use of total coumarins of cnidium fruit in preparing medicaments for treating psoriasis
05/10/2012US20120115939 Methods for using lipoic acid
05/10/2012US20120115937 Ghrelin binding nucleic acids
05/10/2012US20120115936 Potent anti apob antisense compounds
05/10/2012US20120115935 Anti-cancer agent, method for inducing apoptosis of cancer cells, and method for screening for anti-cancer agent
05/10/2012US20120115934 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115933 Organic Compositions to Treat Beta-ENaC-Related Diseases
05/10/2012US20120115932 Modulation of stat 6 expression
05/10/2012US20120115931 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
05/10/2012US20120115930 Compositions and their uses directed to hepcidin
05/10/2012US20120115929 Means And Methods For Counteracting, Preventing And/Or Determining Heart Failure, Or A Risk Of Heart Failure
05/10/2012US20120115928 Mirna and its targets respectively the proteins made based on the targets as a prognostic, diagnostic biomarker and therapeutic agent for cancer
05/10/2012US20120115927 Pharmaceutical agent for preventing cell death
05/10/2012US20120115926 Antisense modulation of apolipoprotein b expression
05/10/2012US20120115925 Allelic Variants Associated with Advanced Age-Related Macular Degeneration
05/10/2012US20120115924 Micro-RNA Mediated Modulation of Colony Stimulating Factors
05/10/2012US20120115923 Sirna Compositions Promoting Scar-Free Wound Healing of Skin and Methods for Wound Treatment
05/10/2012US20120115922 Smac mimetec
05/10/2012US20120115921 Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
05/10/2012US20120115920 Crystalline forms of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
05/10/2012US20120115919 Methods of treating and preventing/reducing the likelihood of mesial temporal lobe epilepsy (tle)
05/10/2012US20120115918 Anti-Viral Compounds
05/10/2012US20120115917 Combination therapy for the management of hypertension
05/10/2012US20120115916 Oxazole and thiazole derivatives as alx receptor agonists
05/10/2012US20120115915 N,n'-diarylurea compounds and n,n'-diarylthiourea compounds as inhibitors of translation initiation
05/10/2012US20120115914 Treatment Methods Employing Histamine H3 Receptor Antagonists, Including Betahistine
05/10/2012US20120115913 Ethanamine Compounds and Methods of Using the Same
05/10/2012US20120115912 Rxr agonist compounds and methods
05/10/2012US20120115910 Compositions and methods for treating parkinson's disease
05/10/2012US20120115909 Tazarotene derivatives
05/10/2012US20120115908 Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
05/10/2012US20120115907 Novel compounds as inhibitors of renin
05/10/2012US20120115906 Derivatives of 3-alkoxy-4,5-diarylthiophene-2-carboxamide, preparation thereof, and therapeutic use thereof
05/10/2012US20120115905 Nitrone, Nitroso, and Nitroxide Spintraps and Spin Labels and Their Hydroxylamines
05/10/2012US20120115904 Compounds having antiparasitic or anti-infectious activity
05/10/2012US20120115903 Substituted Heteroaromatic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115902 3H-Imidazo [4, 5-B] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
05/10/2012US20120115900 Substituted naphthyridine derivatives and their medical use
05/10/2012US20120115899 Naphthyridin-2 (1 h)-one compounds useful as antibacterials
05/10/2012US20120115898 1-pyrazolo[4,3-c]isoquinoline derivatives, preparation thereof and therapeutic use thereof
05/10/2012US20120115897 Aryl (Ethanoic) Propanoic Acid Ascorbyl Ester, Preparation Method Thereof And Medicament Containing The Same
05/10/2012US20120115896 Isogenic human cell lines comprising mutated cancer alleles and process using the cell lines
05/10/2012US20120115895 Tricyclic indole-derived spiro derivatives as crth2 modulators
05/10/2012US20120115894 Imidazole derivatives useful as modulators of faah and as faah imaging agents
05/10/2012US20120115893 Substituted Bicyclic Carboxamide and Urea Compounds as Vanilloid Receptor Ligands
05/10/2012US20120115892 Administration of nedd8-activating enzyme inhibitor
05/10/2012US20120115891 Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
05/10/2012US20120115890 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
05/10/2012US20120115889 Inhibitors of bruton's tyrosine kinase
05/10/2012US20120115886 Fused pyrimidineone compounds as trpv3 modulators
05/10/2012US20120115885 Quinolinone PDE2 Inhibitors
05/10/2012US20120115883 Pyrimidine derivatives which are antagonists of the vitronectin receptor
05/10/2012US20120115882 Spiro amino compounds suitable for the treatment of inter alia sleep disorders and drug addiction
05/10/2012US20120115881 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same
05/10/2012US20120115880 Method for Treating Ocular Cancer
05/10/2012US20120115879 Method of treatment for mental disorders
05/10/2012US20120115878 Salt(s) of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7h-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide and processes of making thereof
05/10/2012US20120115877 Facially Amphiphilic Compounds, Compositions, And Uses Thereof In Treating Cancer
05/10/2012US20120115876 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
05/10/2012US20120115875 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
05/10/2012US20120115874 Pyrazine derivatives, process for manufacture and use thereof
05/10/2012US20120115873 Diazabenzo[de] anthracen-3-one compounds and methods for inhibiting parp
05/10/2012US20120115872 Combination of a sodium-proton exchanger inhibitor and of a dihydro-1,3,5-triazine amine derivative
05/10/2012US20120115871 Method of treatment of depression
05/10/2012US20120115870 Control of intraocular pressure using alk5 modulation agents
05/10/2012US20120115869 Tetrazole derivatives
05/10/2012US20120115868 Novel triazole compounds ii
05/10/2012US20120115867 New class of histone deacetylase inhibitors
05/10/2012US20120115866 Kinase inhibitor compounds
05/10/2012US20120115865 New Salts of an Indole Derivative and Their Use in Medicine
05/10/2012US20120115864 Substituted Fused Pyrimidine Compounds
05/10/2012US20120115863 Compounds for the treatment of cns disorders
05/10/2012US20120115862 Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds
05/10/2012US20120115861 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/10/2012US20120115860 Novel derivatives of aryl--methanone, their method of preparation and their use as medicinal products
05/10/2012US20120115859 3,4,5-substituted piperidines as renin inhibitors
05/10/2012US20120115858 Polymorph Form II of Tanaproget
05/10/2012US20120115857 Novel Polymorphs of Efavirenz
05/10/2012US20120115856 Agent for treatment or prevention of diseases associated with activity of neurotrophic factors
05/10/2012US20120115855 Inhibitors of hcv ns5a
05/10/2012US20120115854 Pharmaceutical composition containing antihypertensive agents
05/10/2012US20120115853 Aryl- and Heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
05/10/2012US20120115852 Heterocyclic compounds as autotaxin inhibitors
05/10/2012US20120115851 Compound inhibiting in vivo phosphorus transport and medicine containing the same
05/10/2012US20120115850 Substituted arylamine compounds and methods of treatment
05/10/2012US20120115849 Treatment of Addiction and Impulse-Control Disorders Using PDE7 Inhibitors
05/10/2012US20120115848 Inhibitors of Polo-Like Kinase
05/10/2012US20120115847 Compounds for the Treatment of Hepatitis C
05/10/2012US20120115846 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof.
05/10/2012US20120115845 Therapeutic agents
05/10/2012US20120115844 Novel triazole compounds i
05/10/2012US20120115843 Novel pyrrolidine derivatives
05/10/2012US20120115842 Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
05/10/2012US20120115841 Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists
05/10/2012US20120115840 Hemifumarate salt of 1-[4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl]-azetidine-3-carboxylic acid
05/10/2012US20120115839 Use of selective gaba a alpha 5 negative allosteric modulators for the treatment of central nervous system conditions
05/10/2012US20120115838 AMPK-Activating Heterocycloalkyloxy(Hetero)Aryl Carboxamide, Sulfonamide And Amine Compounds And Methods For Using The Same
1 ... 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 ... 7860